Cryptosporidium: Discovery and early validation of a drug candidate progresses

Infectious disease scientists from Novartis, the University of Georgia and Washington State University have reported the discovery and early validation of a drug candidate for treating cryptosporidiosis, a diarrheal disease which is a major cause of child mortality in lower-income countries. Currently there are no vaccines or effective treatments. "There's a lot of uncertainty when ["]

The post Cryptosporidium: Discovery and early validation of a drug candidate progresses appeared first on Outbreak News Today.